Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: A correlation with blood-brain-barrier dysfunction

Journal of the Neurological Sciences

Volumn 156, Issue 1, 1998, Pages 53-58

  Giovannoni, G ^a,b   Miller, R F ^c   Heales, S J R ^a,b   Land, J M ^a,b   Harrison, M J G ^c   Thompson, E J ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

AIDS; Cerebrospinal fluid; HIV 1; Nitrate; Nitric oxide; Nitrite; Serum

Indexed keywords

AUTACOID; HUMAN SERUM ALBUMIN; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FUNGAL MENINGITIS; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; MALE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BLOOD-BRAIN BARRIER; FEMALE; HIV-1; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NITRATES; NITRITES; SERUM ALBUMIN;

EID: 18844474156     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00021-5     Document Type: Article

References (41)

1. Bacellar H., Munoz A., Miller E.N., Cohen B.A., Bosley D., Selnes O.A., Beck J.T., McArthur J.C. Temporal trends in the incidence of HIV-1 related neurologic diseases: multicentre AIDS Cohort Study, 1985-1992. Neurology. 44:1994;1892-1900.
2. Bagasara O., Michaels F.H., Zheng Y.M., Bobroski L.E.et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;12041-12045.
3. Barker J.E., Bolanos J.P., Land J.M., Clark J.B., Heales S.J.R. Glutathione protects astrocytes from peroxynitrite mediated mitochondrial damage. Implications for neuronal/astrocytic trafficking and neurodegeneration. Dev. Neurosci. 18:1996;391-396.
4. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
5. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271(5 Pt 1):1996;C1424-C1437.
6. Boje K.M., Arora K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
7. Boje K.M.K. Inhibition of nitric oxide synthase attenuates blood-brain-barrier disruption during experimental meningitis. Brain Res. 720:1996;75-83.
8. Bolaños J.P., Heales S.J.R., Land J.M., Clark J.B. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64:1995;1965-1972.
9. Brosnan C.F., Battistini L., Raine C.S., Dickson D.W., Casadevall A., Lee S.C. Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 16:1994;152-161.
10. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1:1991;163-175.
11. Buster B.L., Weintrob A.C., Townsend G.C., Scheld W.M. Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect. Immun. 63:1995;3835-3839.
12. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric-oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
13. de Vera M.E., Shapiro R.A., Nussler A.K., Mudgett J.S., Simmons R.L., Morris S.M. Jr., Billiar T.R., Geller D.A. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines - initial analysis of the human NOS2 promoter. Proc. Natl. Acad. Sci. USA. 93:1996;1054-1059.
14. Egberts J., Soederhuizen W. Urine samples before dinner are preferable when studying changes in endogenous nitrate production under uncontrolled dietary conditions. Clin. Chim. Acta. 254:1996;141-148.
15. Everall I.P., Luthert P.J., Lantos P.L. Neuronal loss in the frontal cortex in HIV infection. Lancet. 337:1991;1119-1121.
16. Felgenhauer, K., Liappis, N., Nekic, M., 1982. Low molecular solutes and the blood cerebrospinal fluid barrier. Klin. Wochenschr. 60, 1385-1392.
17. Giovannoni, G., Heales, S.J.R., Silver, N.C., O'Riordan, J., Miller, R.F., Land, J.M., Clark, J.B., Thompson, E.J., 1997a. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J. Neurol. Sci. 145, 77-81.
18. Giovannoni, G., Land, J.M., Keir, G., Thompson, E.J., Heales, S.J.R., 1997b. Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann. Clin. Biochem. 34, 193-198.
19. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 269:1994;29405-29408.
20. Hurst R.D., Fritz I.B. Nitric oxide-induced perturbations in a cell culture model of the blood-brain barrier. J. Cell Physiol. 167:1996;89-94.
21. Inoue S., Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett. 371:1995;86-88.
22. Ketzler S., Weiss S., Haug H., Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. (Berlin). 80:1990;92-94.
23. Lane T.E., Buchmeier M.J., Watry D.D., Fox H.S. Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIV infected rhesus monkeys - applications to HIV-induced central nervous system disease. Mol. Med. 2:1996;27-37.
24. Langrehr J.M., Hoffman R.A., Lancaster J.R., Simmons R.L. Nitric oxide - a new endogenous immunomodulator. Transplantation. 55:1993;1205-1212.
25. Laurell C.B. Electroimmunoassay. Scand. J. Clin. Lab. Invest. 29:1972;21-37.
26. Lee S.C., Dickson D.W., Liu W., Brosnan C.F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1-beta and interferon gamma. J. Neuroimmunol. 46:1993;19-24.
27. Lipton S.A., Gendelman H.E. Dementia associated with acquired immunodeficiency syndrome. N. Engl. J. Med. 332:1995;934-940.
28. Mackenzie-Graham A.J., Mitrovic B., Smoll A., Merrill J.E. Differential sensitivity to nitric oxide in immortalised, cloned murine oligodendrocyte cell lines. Dev. Neurosci. 16:1994;162-171.
29. Masliah E., Achim C.L., Ge N., DeTeresa R., Terry D., Wiley C.A. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32:1992;321-329.
30. Mateo R.B., Reichner J.S., Mastrofrancesco B., Kraft Stolar D., Albina J.E. Impact of nitric oxide on macrophage glucose metabolism and glyceraldehyde-3-phosphate dehydrogenase activity. Am. J. Physiol. 268:1995;669-675.
31. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
32. Milstien S., Sakai N., Brew B.J., Krieger C., Vickers J.H., Saito K., Heyes M.P. Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J. Neurochem. 63:1994;1178-1180.
33. Mitrovic B., Ignarro L.J., Montestruque S., Smoll A., Merrill J.E. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience. 61:1994;575-585.
34. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:1993;2002-2012.
35. Roy B., Lepoivre M., Henry Y., Fontecave M. Inhibition of ribonucleotide reductase by nitric oxide derived from thionitrites: reversible modifications of both subunits. Biochemistry. 34:1995;5411-5418.
36. Sharief M.K., Noori M.A., Ciardi M., Cirelli A., Thompson E.J. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage. J. Neuroimmunol. 43:1993;15-22.
37. Shulka A., Dikshit M., Srimal R.C. Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium. Neuroreport. 6:1995;1629-1632.
38. Torre D., Ferrario G., Speranza F., Martegani R., Zerolli C. Increased levels of nitrite in the sera of children infected with human immunodeficiency virus type 1. Clin. Infect. Dis. 22:1996;650-653.
39. Wiley C.A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann. Neurol. 29:1991;651-657.
40. Zangerle R., Fuchs D., Reibnegger G., Warner-Felmayer G., Gallati H., Wachter H., Werner E.R. Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1. Immunobiology. 193:1995;59-70.
41. Zielasek J., Jung S., Gold R., Liew F.Y., Toyka K.V., Hartung H.-P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.